Veris Residential Goes Private in $3.5B Affinius Deal
Affinius Capital and Vista Hill Partners completed a $3.5B all-cash take-private of Veris Residential on May 27, paying $19/share — a 23.2% premium.
Stock market news and analysis, with explanations of company developments, earnings and the forces moving share prices. Start with Market Education if you are new to investing. Find your way around ECMSource.
Affinius Capital and Vista Hill Partners completed a $3.5B all-cash take-private of Veris Residential on May 27, paying $19/share — a 23.2% premium.
AST SpaceMobile (ASTS) shed nearly 18% Friday after a Blue Origin New Glenn engine test exploded at Cape Canaveral, rattling the entire space-stock complex.
Wall Street wants the Fed to formally codify Vice Chair Bowman’s supervisory rollbacks before a future administration can undo them.
Kevin Warsh was sworn in as Fed Chair on May 22, replacing Jerome Powell. Treasury yields fell across the curve in his first week.
Incyte’s Phase 3 frontMIND trial cut DLBCL progression risk 25% with tafasitamab + Revlimid + R-CHOP, but severe adverse events and deaths from toxicity ran ahead of standard care.
Nvidia returned $20B in Q1, added an $80B buyback authorization, and lifted its dividend 25x – even as it zeroed China out of its outlook.
Ambarella stock tumbled 21% Friday despite a Q1 FY27 earnings beat. In-line Q2 guidance disappointed a market priced for upside.
Clinical-stage heart-drug developer Kardigan filed its S-1 for a Nasdaq IPO (ticker: KARD), backed by a JPM/Jefferies/Leerink/TD Cowen syndicate.
FDIC and the Fed cleared all 8 US G-SIBs’ 2025 resolution plans on May 22, 2026 — no shortcomings, no deficiencies, and 2023 derivatives gaps now fixed.
Lantheus Holdings (LNTH) is weighing a roughly $7 billion takeover bid from PE-backed Curium Pharma. Shares jumped 9% on the report.